Calcium and Vitamin D Supplementation Guidelines

Primary Indications

Patients with documented osteoporosis should receive calcium and vitamin D as an integral component of their management strategy, particularly when taking antiresorptive or anabolic medications, as recommended by the American College of Physicians 1, 2.
Supplementation is clearly indicated for individuals with documented vitamin D deficiency, as stated by the American College of Physicians 1, 2.
The USPSTF recommends vitamin D supplementation (median dose 800 IU) to prevent falls in community-dwelling adults aged ≥65 years with a history of recent falls or vitamin D deficiency, as recommended by the US Preventive Services Task Force 1, 2, 4, 3.

Patients with impaired kidney function require vitamin D supplementation, as the kidneys cannot adequately activate vitamin D, leading to reduced calcium absorption, according to the National Kidney Foundation 5, 6.

The USPSTF recommends AGAINST daily supplementation with ≤400 IU vitamin D3 and ≤1000 mg calcium in non-institutionalized postmenopausal women (Grade D recommendation), as stated by the US Preventive Services Task Force 1, 2, 7, 5, 6.
Evidence is insufficient to recommend routine supplementation in premenopausal women or men without specific risk factors, according to the American College of Physicians 1, 2, 7, 3.

Higher vitamin D doses (≥800 IU) may be more effective than lower doses, though evidence remains insufficient for definitive conclusions, as noted by the National Institutes of Health 5.
Calcium intake should be spread throughout the day, as the gut cannot absorb more than 500 mg at once, according to the National Institutes of Health 5, 6.

Supplementation with vitamin D and calcium increases kidney stone risk (hazard ratio 1.17), with 1 additional stone per 273 women treated over 7 years, as reported by the American College of Physicians 1, 2, 4, 3, 5.
This harm must be weighed against potential benefits in individual patients, as stated by the American College of Physicians 1.

Do not supplement routinely without assessing individual risk factors - the USPSTF evidence clearly shows no benefit and potential harm in low-risk populations, as recommended by the US Preventive Services Task Force 1, 2, 7.
Do not assume all postmenopausal women need supplementation - target those with osteoporosis, vitamin D deficiency, or high fracture risk, according to the National Osteoporosis Foundation 1, 3.